EQT related stories
All articles and analysis
Tech valuations: Down, but not outThere may be disruption in the public markets, but tech verticals are still being primed for growth, whatever the future holds.
Three key trends for investing in technologyA renewed focus on value creation and specific verticals may pay dividends for tech investments despite market volatility.
The growth of impact investingAs the market matures, funds are finding ways to stand out from the crowd while LPs dial up demands for transparency.
Impact themes in focus: ClimateInvestor appetite for climate-orientated solutions is growing as a political push for action accelerates momentum.
Currency volatility: A welcome tailwind for PE?Foreign exchange is too unpredictable to influence private equity decisions in the long run, but some portfolio companies could receive a boost from FX shifts in the near term.
Side Letter: BPEA EQT's top concern; Japan's LP budget constraints; PAI's ESG bossEQT's chief executive and its Asia chairman share their concerns for private equity in Asia-Pacific. Plus: Why Japan's currency concerns may extend into next year; and France's PAI has a new ESG boss. Here's today's brief, for our valued subscribers only.
EQT mulls bulking up private wealth offering in ‘competitive’ fundraising environmentThe Swedish firm is in market with its 10th flagship fund, which held a €15bn first close in August and has a target of €20bn.
Side Letter: EQT’s €50bn; Alaska's PE boss; Harvard mulls markdownsEQT will look to bolt-ons, the energy transition and take-privates to help deploy a mountain of dry powder next year. Plus: Alaska Permanent Fund has a new private equity boss; and Harvard is anticipating markdowns. Here's today's brief, for our valued subscribers only.
Side Letter: KKR anchors Atwater; Ardian's iCap tie-up; impact-linked carry crewKKR turns LP for an alum's media and entertainment fund. Plus: Ardian says 'oui' to more private wealth capital and another firm is tying carried interest to impact. Here's today's brief, for our valued subscribers only.
OpEx Awards 22: Americas Large-cap winner – EQTEQT positioned biotechnology company Aldevron for continued growth by investing in new facilities, systems and mRNA and protein manufacturing capabilities.